Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Management of Adults and Adolescents with Alopecia Areata
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Sickle Cell Disease Transition in Care
Release Date:
Partner: National Alliance of Sickle Cell Centers
Review Process: Expert Review Panel
Quality Improvement Rare Disease USA
Title
Grant Type
Focus Area
Country
Application Due Date
Education for Improving Appropriate Diagnosis and Treatment for Venous Thromboembolism
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine Japan
Education and Support for Patients with Locally-Advanced or Metastatic Bladder Cancer
Release Date:
Partner: Merck KGaA, Darmstadt, Germany and EMD Serono
Review Process: Pfizer Internal
Education Oncology USA
Pre-clinical & Translational Research in Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Research Oncology Canada, USA
Management of Patients with BRAF-mutant metastatic colorectal cancer
Release Date:
Review Process: Pfizer Internal
Education Oncology Canada, USA
Quality Improvement Grants to Support the Delivery of Gene Therapies to Patients with Rare Disease
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease All
Promotion of Smoking Cessation Treatment in General Practice
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine Japan
2021 Growth Hormone Research (All countries except for the United States)
Release Date:
Review Process: Pfizer Internal
Research Rare Disease All
Closing Knowledge Gaps in Osteoarthritis and Osteoarthritis Pain
Release Date:
Partner: Lilly
Review Process: Pfizer Internal
Education Internal Medicine All
NSCLC Therapy Management for Optimal Outcomes
Release Date:
Review Process: Pfizer Internal
Quality Improvement Oncology Andorra, Austria, Belgium, Canada, Denmark, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Monaco, Netherlands, Norway, Portugal, San Marino, Spain, Sweden, Switzerland, USA, United Kingdom
Educational Program to Increase Awareness and Treatment of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease China
Clinical Research Capability Development
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine China
Advances in Moderate-to-Severe Atopic Dermatitis for Dermatologists and Allergists
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA